Source Post
Why Is Novo Nordisk Stock Falling? | #nvostock #nvo #novonordisk #stocks #crypto #trading #investing
Aug 6, 2025
Novo Nordisk has lowered its 2025 growth expectations due to lower demand for Wegovy in the US obesity market, slower than anticipated international penetration, and competition from Eli Lilly. The company also faces challenges with compounded versions of its drugs being sold through channels like Hims and Hers Health.
Linked Mentions
Tickers discussed in this post
Linked Signals
Tracked calls opened from this post
No linked signals were opened directly from this post.